title: Prokaryotical expression of structural and non-structural proteins of hepatitis G virus.
abstract: OBJECTIVE
  To study the epitope distribution of hepatitis G virus (HGV) and to seek for the potential recombinant antigens for the development of HGV diagnostic reagents.
  
  
  METHODS
  Fourteen clones encompassing HGV gene fragments from core to NS3 and NS5 were constructed using prokaryotic expression vector pRSET and (or) pGEX, and expressed in E.coli. Western blotting and ELISA were used to detect the immunoreactivity of these recombinant proteins.
  
  
  RESULTS
  One clone with HGV fragment from core to E1 (G1), one from E2 (G31), three from NS3 (G6, G61, G7), one from NS5B (G821) and one chimeric fragment from NS3 and NS5B (G61-821) could be expressed well and showed obvious immunoreactivity by Western blotting. One clone with HGV framment from NS5B (G82) was also well expressed, but could not show immunoreactivity by Western blotting. No obvious expression was found in the other six clones. All the expressed recombinant proteins were in inclusion body form, except the protein G61 which could be expressed in soluble form. Further purified recombinant proteins G1, G31, G61, G821 and G61-821 were detected in indirected ELISA as coating antigen respectively. Only recombinant G1 could still show immunoreactivity, and the other four recombinant proteins failed to react to the HGV antibody positive sera. Western blotting results indicated that the immunoactivity of these four recombinant proteins were lost during purification.
  
  
  CONCLUSIONS
  Core to E1, E2, NS3 and NS5 fragment of HGV contain antigenic epitopes, which could be produced in prokaryotically expressed recombinant proteins. A high-yield recombinant protein (G1) located in HGV core to E1 could remain its epitope after purification, which showed the potential that G1 could be used as a coating antigen to develop an ELISA kit for HGV specific antibody diagnosis.
authors.affiliation: Key Laboratory of the Ministry of Education for Cell Biology and Tumor Cell Engineering, Xiamen University, Xiamen 361005, Fujian Province, China. nsxia@jingxian.xmu.edu.cn
authors.forename: N S
authors.initials: NS
authors.lastname: Xia
authors.forename: H J
authors.initials: HJ
authors.lastname: Yang
authors.forename: J
authors.initials: J
authors.lastname: Zhang
authors.forename: C Q
authors.initials: CQ
authors.lastname: Lin
authors.forename: Y B
authors.initials: YB
authors.lastname: Wang
authors.forename: J
authors.initials: J
authors.lastname: Wang
authors.forename: M Y
authors.initials: MY
authors.lastname: Zhan
authors.forename: M
authors.initials: M
authors.lastname: Ng
mesh_terms: D015153:Blotting, Western; D004797:Enzyme-Linked Immunosorbent Assay; D018604:Epitope Mapping; D004926:Escherichia coli / Q000235:genetics*; D029407:GB virus C / Q000235:genetics* / Q000302:isolation & purification*; D015967:Gene Expression Regulation, Viral; D006801:Humans; D010957:Plasmids; D011994:Recombinant Proteins / Q000235:genetics; D014759:Viral Envelope Proteins / Q000032:analysis / Q000235:genetics*; D017361:Viral Nonstructural Proteins / Q000032:analysis / Q000235:genetics
chemical_list: C115108:NS3 protein, African horse sickness virus; D011994:Recombinant Proteins; D014759:Viral Envelope Proteins; D017361:Viral Nonstructural Proteins; C114224:envelope protein E1, GB virus C; C107619:glycoprotein E2, GB virus C